The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 19, 2019
Filed:
Apr. 13, 2018
Applicant:
Obseva S.a., Plan-les-Ouates, CH;
Inventors:
Andre Chollet, Plan-les-Ouates, CH;
Oliver Pohl, Plan-les-Ouates, CH;
Assignee:
ObsEva S.A., Plan-les-Ouates, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/401 (2006.01); A61K 9/20 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 47/40 (2006.01); A61K 31/40 (2006.01); A61P 15/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/40 (2013.01); A61K 9/0056 (2013.01); A61K 9/0095 (2013.01); A61K 9/20 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2031 (2013.01); A61K 9/2054 (2013.01); A61K 31/401 (2013.01); A61K 45/06 (2013.01); A61K 47/40 (2013.01); A61P 15/08 (2018.01);
Abstract
The present invention relates to solid oral formulations comprising a compound of formula (3Z,5S)-5-(hydroxymethyl)-1-[(2'-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one-O-methyloxime, and/or an active metabolite thereof, and the use of said formulations in the treatment and/or prevention of preterm labor, premature birth, dysmenorrhea and embryo implantation failure due to uterine contractions. The present invention is furthermore related to processes for their preparation.